SEC Form 4 · accession 0001209191-17-038562
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Taylor Sandison
Officer — Chief Medical Officer
Period of report
Jun 6, 2017
Accepted (ET)
Jun 8, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2017 | P | 656 | $5.90 | A | 6,351 | D | |
| Common Stock | Jun 7, 2017 | P | 19,344 | $5.90 | A | 25,695 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,841 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 19, 2017.